Our research group is focused on investigating the intricate mechanisms by which mechanobiology impacts cancer progression. We study the intricate interplay between metabolism, immune evasion, and cancer progression. Specifically, we aim to elucidate the influence of biochemical and mechanical signals arising from the tumor microenvironment, which have been shown to modulate the mechanical properties of cancer and stromal cells, and ultimately dictate cancer cell behavior, including migration and drug responses.
Our current research goals are centered on identifying the molecular mediators that promote cancer cell survival and motility. Through a thorough exploration of these critical factors, we aspire to develop novel anti-cancer treatment strategies that may ultimately enhance patient outcomes.